INS and type 2 diabetes mellitus: Since adiponectin improves insulin sensitivity, while resistin and pro-inflammatory cytokines lower it [13], altogether, these alterations in the adipokine and cytokine levels lead to decreased whole-body insulin sensitivity, to compensatory increases in circulating plasma insulin levels, and later to the development of type-2 diabetes mellitus [14,15,16].